7. Johnson & Johnson CEO Alex Gorsky
Alex Gorsky, a former Army Ranger with a laser focus, has been working overtime to get Johnson & Johnson’s (JNJ) problems — including massive quality control issues and a criminal complaint over marketing of an antipsychotic drug –behind it.
So far, the Johnson & Johnson CEO is doing a pretty good job. After settlements — although in the billions — for both issues, it seems that the worst is finally behind the 127-year old pharmaceutical giant. Oh yeah, and Alex Gorsky is taking bids for the company’s Ortho Clinical Diagnostics unit, which is believed to be worth somewhere in the $4 billion range.
The result: JNJ stock is beating the market with a 32% climb this year.